5 Horizons Capital

5 Horizons Capital operates a Venture Capital-as-a-Service platform, exclusively for clinical-stage biotechnology companies. The firm combines essential capital with strategic advisory and critical CRO partnerships, offering comprehensive support for biotechs conducting in-human clinical trials. This integrated model streamlines the complex process of therapeutic development.

Established in 2022 and based in Oklahoma City, 5 Horizons Capital was co-founded by Aaron Ray, Managing Partner, and Bill Cronin, a Partner bringing over three decades of investment experience. Their insight addressed significant funding and execution gaps within the biotech sector, aiming to bridge the critical divide between initial scientific discovery and successful clinical validation.

The platform supports biotech leaders engaged in or approaching their first-in-human trials, providing tailored resources to advance medical innovations. 5 Horizons Capital's vision is to be an indispensable partner, committed to accelerating transformative treatments through sustained support for vital clinical milestones.